Anzeige
Mehr »
Login
Donnerstag, 29.10.2020 Börsentäglich über 12.000 News von 650 internationalen Medien
Unglaublicher News-Flow!!! Diese Firma liefert einfach gewaltig ab!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JB4Y ISIN: US42237K3005 Ticker-Symbol: 1HB1 
Tradegate
29.10.20
21:44 Uhr
0,976 Euro
-0,026
-2,55 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
HEAT BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
HEAT BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,9760,99523:00
0,9761,00321:58

Aktuelle News zur HEAT BIOLOGICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:41Neue sensationelle Prognose für alle Heat Biologics Aktionäre - Jetzt wird die Aktie alles andere übertreffen, das ist der Grund
HEAT BIOLOGICS Aktie jetzt für 0€ handeln
07.10.Heat Biologics secures new patent related to gp96 platform50
07.10.Heat Biologics, Inc.: Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator877New patent covers ICOS T cell co-stimulation in combination with Heat's proprietary gp96 platform DURHAM, NC / ACCESSWIRE / October 7, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage...
► Artikel lesen
17.09.Heat Biologics News: Why HTBX Stock Is On the Move Today61
09.09.Heat Biologics, Inc.: Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th1.094DURHAM, NC / ACCESSWIRE / September 9, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune...
► Artikel lesen
08.09.Heat Biologics: Meet the team behind a robust COVID-19 vaccine67
02.09.Heat Biologics nabs new U.S. patent covering gp96 platform67
02.09.Heat Biologics, Inc.: Heat Biologics Issued Key Patent on Combination Platform Therapy1.081Superior pre-clinical activity compared to conventional costimulatory antibody combination administered systemically DURHAM, NC / ACCESSWIRE / September 2, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX)...
► Artikel lesen
26.08.Why Heat Biologics Stock Is Popping Today53
26.08.Heat Biologics COVID-19 vaccine shows encouraging action in preclinical study48
26.08.Heat Biologics, Inc.: Heat Biologics Announces Publication of Preclinical COVID-19 Vaccine Results623Data supports a differentiated gp96-based COVID-19 vaccine that induces systemic and tissue-specific (lung) memory CD8+ T cells Gp96-based vaccine generates tissue-resident memory CD8+ T cells that...
► Artikel lesen
24.08.Why Heat Biologics, Inovio Pharmaceuticals, and Novavax Are Getting Clobbered Today299
24.08.HEAT BIOLOGICS, INC. - 8-K, Current Report52
14.08.Stock Alert: Heat Biologics Down 9%74
13.08.Why Heat Biologics Stock Surged Today52
13.08.Encouraging COVID-19 vaccine data lifts Heat Biologics, up 24%59
13.08.Heat Biologics, Inc.: Heat Biologic's COVID-19 Vaccine Demonstrates Robust T Cell Driven Immune Response to SARS-CoV-2 in Preclinical Studies1.570T cell driven immune response achieved with just a single dose Potential to be used in combination with other COVID-19 vaccine approaches DURHAM, NC / ACCESSWIRE / August 13, 2020 / Heat Biologics...
► Artikel lesen
11.08.Why Dynavax Technologies, Heat Biologics, and Inovio Pharmaceuticals Are Cratering Today136
07.08.HEAT BIOLOGICS, INC. - 10-Q, Quaterly Report33
07.08.HEAT BIOLOGICS, INC. - 8-K, Current Report33
Seite:  Weiter >>
76 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
69,1,89